This most recent twist while in the Lykos Therapeutics saga threatens a major overhaul of the business’s tactic and way, with Musk ally and billionaire investor Antonio Gracias showing up to desire to consider the corporate back towards its nonprofit drug progress roots and a far more Doblinite philosophy.“I expended the weekend chatting a grea